S359241

DTP-HepB-Hib vaccine,vial of 1 dose


DTP-HepB-Hib vaccine, vial of 1 dose.
Indicative Price 1.16 USD

General Description:
DTP-HepB-Hib vaccine, vial of 1 dose

The vaccine is a homogeneous liquid containing purified diphtheria and tetanus toxoids, inactivated whooping cough (pertussis) organisms, highly purified, non-infectious particles of hepatitis B surface antigen (HBsAg) and Hib component as a bacterial subunit vaccine containing highly purified, non-infectious Haemophilus influenzae type b (Hib) capsular polysaccharide chemically conjugated to a carrier.

For information on product specifications, refer to the WHO website on Prequalified Vaccines.

https://www.who.int/immunization_standards /vaccine_quality/PQ_vaccine_list_en/en/

Administration:
The liquid vaccine vial should be shaken before use to homogenize the suspension. The vaccine should be injected intramuscularly. The anterolateral aspect of the upper thigh is the preferred site of injection, or into the deltoid muscles of older children or adults. An injection into child's buttocks may cause injury to the sciatic nerve and is not recommended. It must not be injected into the skin as this may give rise to local reaction. One paediatric dose is 0.5 ml. A sterile syringe and sterile needle must be used for each injection.

Immunization Schedule:
DTwP-HepB-Hib vaccine should NOT be used for the birth dose.

In countries where pertussis is of particular danger to young infants, the combination vaccine should be started as soon as possible with the first dose given as early as 6 weeks, and two subsequent doses given at 4-week intervals.

The DTwP-HepB-Hib vaccine can be given safely and effectively at the same time as BCG, measles, polio (OPV or IPV), and yellow fever vaccines and vitamin A supplementation. If DTwP-HepB-Hib vaccine is given at the same time as other vaccines, it should be administered at a separate site. It should not be mixed in the vial or syringe with any other vaccine unless it is licensed for use as a combined product.

Transport and Storage:
The components of the combination vaccine must be stored and transported between +2°C and +8 °C. The vaccine must not be frozen.
Related Products